Title: Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.
Journal: Molecular biology reports 20111101
Title: Histone deacetylase inhibition improves activation of ribosomal RNA genes and embryonic nucleolar reprogramming in cloned mouse embryos.
Journal: Biology of reproduction 20111101
Title: Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Journal: The Journal of biological chemistry 20110624
Title: Oxamflatin significantly improves nuclear reprogramming, blastocyst quality, and in vitro development of bovine SCNT embryos.
Journal: PloS one 20110101
Title: Inhibition of class IIb histone deacetylase significantly improves cloning efficiency in mice.
Journal: Biology of reproduction 20101201
Title: A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patients.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100915
Title: Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin.
Journal: Molecular cancer therapeutics 20080501
Title: Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
Journal: Molecular cancer therapeutics 20061201
Title: Conformational analogues of Oxamflatin as histone deacetylase inhibitors.
Journal: Organic & biomolecular chemistry 20061021
Title: Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Journal: Cell death and differentiation 20040901
Title: Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Journal: Cancer research 20030801
Title: Kim YB, et al. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. Oncogene. 1999 Apr 15;18(15):2461-70.
Title: Wang YL, et al. HDAC Inhibitor Oxamflatin Induces Morphological Changes and has Strong Cytostatic Effects in Ovarian Cancer Cell Lines. Curr Mol Med. 2016;16(3):232-42.
Title: Faghihloo E, et al. The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line. Cancer Gene Ther. 2016 Nov;23(11):396-399.
